Senseonics Holdings, Inc. (SENS): Price and Financial Metrics
Senseonics Holdings, Inc. (SENS)
Today's Latest Price: $0.98 USD
0.01 (-1.01%)
Updated Dec 13 12:00am
Add SENS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 55 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
SENS Stock Summary
- With a price/sales ratio of 12.86, Senseonics Holdings Inc has a higher such ratio than 92.05% of stocks in our set.
- Revenue growth over the past 12 months for Senseonics Holdings Inc comes in at 76.01%, a number that bests 92.9% of the US stocks we're tracking.
- The volatility of Senseonics Holdings Inc's share price is greater than that of 92.55% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Senseonics Holdings Inc, a group of peers worth examining would be VJET, SWIR, NVTA, SONO, and DOMO.
- SENS's SEC filings can be seen here. And to visit Senseonics Holdings Inc's official web site, go to www.senseonics.com.
SENS Daily Price Range
SENS 52-Week Price Range
SENS Stock Price Chart More Charts
SENS Price/Volume Stats
| Current price | $0.98 | 52-week high | $3.37 |
| Prev. close | $0.99 | 52-week low | $0.80 |
| Day low | $0.95 | Volume | 1,535,500 |
| Day high | $1.02 | Avg. volume | 1,722,994 |
| 50-day MA | $1.00 | Dividend yield | N/A |
| 200-day MA | $1.59 | Market Cap | 199.38M |
Senseonics Holdings, Inc. (SENS) Company Bio
Senseonics Holdings, Inc. focuses on the design, development, and commercialization of glucose monitoring systems for people with diabetes. The company was founded in 1996 and is based in Germantown, Maryland.
Top Stories View All
Best & Worst Performing Stock Industries for December 13, 2019
Best & Worst Performing Small Cap Stocks for December 13, 2019
Best & Worst Performing Mid Cap Stocks for December 13, 2019
Best & Worst Performing Large Cap Stocks for December 13, 2019
Best & Worst Performing Mega Cap Stocks for December 13, 2019
View All Top Stories
Loading social stream, please wait...